Angus, United Kingdom

William Joseph Harris


Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 139(Granted Patents)


Location History:

  • Carnoustie, GB (1997 - 2002)
  • Angue, GB (2002)
  • Angus, GB (2001 - 2004)

Company Filing History:


Years Active: 1997-2004

Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovations of William Joseph Harris

Introduction

William Joseph Harris is a notable inventor based in Angus, GB, recognized for his significant contributions to the field of biotechnology. With a total of 16 patents to his name, Harris has made remarkable advancements, particularly in the development of humanized monoclonal antibodies.

Latest Patents

Harris's latest patents include high affinity humanized anti-TAG-72 monoclonal antibodies. These novel humanized monoclonal antibodies, along with their fragments and derivatives, specifically bind to TAG-72. The methods for their manufacture are also detailed in his patents. These humanized antibodies are particularly useful in the treatment of cancers that express TAG-72, as well as for diagnostic purposes, such as in vivo imaging of tumors or cancer cells that express TAG-72.

Career Highlights

Throughout his career, Harris has worked with prestigious organizations, including The Dow Chemical Company and Memorial Sloan Kettering Cancer Center. His work has significantly impacted cancer research and treatment methodologies.

Collaborations

Harris has collaborated with notable individuals in his field, including Frank J. Carr and Philip Ronald Tempest. Their combined expertise has contributed to the advancement of innovative solutions in cancer treatment.

Conclusion

William Joseph Harris stands out as a prominent inventor whose work in monoclonal antibodies has the potential to transform cancer diagnostics and therapies. His contributions continue to influence the field of biotechnology significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…